Literature DB >> 16823017

Successful use of recombinant factor VIIa for treatment of severe postpartum hemorrhage.

Ankie E W Hamaekers1, Walther N K A van Mook, J P M Offermans, Marco A E Marcus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16823017

Source DB:  PubMed          Journal:  Am J Crit Care        ISSN： 1062-3264            Impact factor:   2.228


× No keyword cloud information.
  2 in total

1.  Recombinant activated factor VII (rFVIIa/NovoSeven®) in the management of severe postpartum haemorrhage: initial report of a multicentre case series in Japan.

Authors:  Takao Kobayashi; Masao Nakabayashi; Akira Yoshioka; Makoto Maeda; Tsuyomu Ikenoue
Journal:  Int J Hematol       Date:  2011-12-09       Impact factor: 2.490

2.  Timely 'off-label' use of recombinant activated factor VII (NovoSeven(®)) can help in avoiding hysterectomy in intractable obstetric bleeding complicated with disseminated intravascular coagulation: A case report and review of the literature.

Authors:  Jyoti Burad; Pradipta Bhakta; Jasvinder Sharma
Journal:  Indian J Anaesth       Date:  2012-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.